Avricore Health (TSE:AVCR) has released an update.
Avricore Health has announced a strategic pivot to focus on the growing UK healthcare market, concluding its partnership with Canada’s Shoppers Drug Mart. This move is backed by the significant NHS investment in pharmacy services, which presents a larger opportunity for their HealthTab™ platform. The company maintains a strong cash position to support this expansion and has already initiated deployment in London.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
